Skip to content
AnalystLens

Somnigroup International 8-K Report, Regulation FD Disclosure (May 8, 2024)

Reports
Regulation FD·Exhibits & Filings
Filing Date
Filed May 8, 2024
Period End
May 7, 2024
Security
SGI
In the record · 2016–202610-K1110-Q328-K220

SGI filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 220 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Mar ’18Mar ’18
  2. Material agreement8-K · May ’20May ’20
  3. Leadership change8-K · Jul ’22Jul ’22
  4. Deal closed8-K · Aug ’26Aug ’26

Summary

Summary of the 8-K filed May 8, 2024. Cited figures are marked; the original filing is the authoritative source.

Tempur Sealy International, Inc. furnished an updated investor presentation dated May 7, 2024 under Item 7.01 (Regulation FD Disclosure) of this Form 8-K, with the presentation attached as Exhibit 99.1.

The presentation reviews the company's brands (Tempur-Pedic, Sealy, Stearns & Foster), omni-channel distribution, and first-quarter 2024 results. For the trailing twelve months ended March 31, 2024, net sales were $4,906.7 milliona versus $4,889.8 million a year earlier, while GAAP net income fell to $359.1 million from $455.7 million, GAAP EPS fell to $2.02 from $2.52, and adjusted EBITDA rose to $877.8 million from $855.3 million. For the three months ended March 31, 2024, net sales were $1,189.4 million versus $1,208.1 million, GAAP net income was $76.3 million versus $85.3 million, and adjusted EPS was $0.43 versus $0.53 on a GAAP basis and $0.50 versus $0.53 on an adjusted basis.

The company's 2024 outlook calls for adjusted EPS between $2.60b and $2.90, sales growth of low to mid-single digits, record advertising spend of approximately $500 million, and adjusted EBITDA of approximately $1 billion at the midpoint. Management expects U.S. produced mattress units to be flat to slightly down in 2024, with headwinds in the first half and some recovery in the second half. The presentation also covers the pending acquisition of Mattress Firm, described as a total purchase price of approximately $4.0 billion, consisting of $2.7 billion in cash and $1.3 billion in stock (34.2 million shares), with a closing anticipated in the second half of 2024 and subject to regulatory approvals.

Net leverage is estimated at 3.0xc to 3.25x at closing, with a return to the 2.0x to 3.0x target range expected within twelve months after closing. The information in Item 7.01 and Exhibit 99.1 is furnished and not deemed filed for purposes of Section 18 of the Exchange Act.

The presentation is intended for use in investor meetings, and the company notes that it is not reconfirming its previously issued guidance as of the presentation date. The company is now Somnigroup International.

Key Highlights

  1. Trailing twelve-month GAAP net income declined to $359.1 million from $455.7 million, and GAAP EPS declined to $2.02 from $2.52, while trailing twelve-month adjusted EBITDA rose to $877.8 million from $855.3 million.
  2. For the three months ended March 31, 2024, net sales were $1,189.4 million versus $1,208.1 million, and adjusted EPS was $0.50 versus $0.53.
  3. 2024 outlook: adjusted EPS of $2.60 to $2.90, sales growth of low to mid-single digits, approximately $500 million of advertising, and adjusted EBITDA of approximately $1 billion at the midpoint.
  4. Pending Mattress Firm acquisition: total purchase price of approximately $4.0 billion ($2.7 billion cash and $1.3 billion stock), with cost synergies of $100 million by year four and a closing anticipated in the second half of 2024.
  5. Pro forma ownership at signing is 83.4% for existing TPX shareholders and 16.6% for Mattress Firm shareholders; net leverage is estimated at 3.0x to 3.25x at closing.
  6. Liquidity and debt: over $1 billion of liquidity, a $1.15 billion revolving credit facility, a $500 million term loan, and no meaningful maturities until 2028; the February 2024 amendment provides for increased loan commitments of up to $625 million.
  7. U.S. industry outlook: management anticipates U.S. produced mattress units to be flat to slightly down in 2024, with headwinds in the first half and some recovery in the second half.

Frequently Asked Questions

  1. How did Tempur Sealy perform in the first quarter of 2024?

    For the three months ended March 31, 2024, net sales were $1,189.4 million, down from $1,208.1 million, and net income was $76.3 million, down from $85.3 million. Adjusted EBITDA was $198.2 million, up from $197.7 million, and adjusted EPS was $0.50, down from $0.53.

  2. What is the company's full-year 2024 guidance?

    The company expects adjusted EPS between $2.60 and $2.90, sales growth of low to mid-single digits compared with the prior year, record advertising spend of approximately $500 million, and adjusted EBITDA of approximately $1 billion at the midpoint. The presentation notes that the company is not reconfirming this guidance as of the presentation date.

  3. What are the terms of the Mattress Firm acquisition?

    The total purchase price is approximately $4.0 billion, comprising $2.7 billion in cash and $1.3 billion in stock based on 34.2 million shares issued at $37.62 per share. Mattress Firm will operate as a separate business unit, the TPX Board will add two Mattress Firm directors, and closing is anticipated in the second half of 2024, subject to customary conditions and regulatory approvals.

  4. How will the Mattress Firm deal affect the company's leverage and financing?

    The company expects to fund the cash payment and the repayment of Mattress Firm's debt with cash on hand and new senior secured and senior unsecured debt. Net leverage is estimated at 3.0x to 3.25x at closing, with a return to the 2.0x to 3.0x target range expected within the first twelve months after closing, driven by expected operating cash flow and adjusted EBITDA growth.

  5. What is the outlook for the U.S. bedding industry?

    Management anticipates U.S. produced mattress units will be flat to slightly down in 2024, with headwinds in the first half and some recovery in the second half. The presentation notes that 2022 and 2023 unit volumes were well below the industry 20-year average of 21.7 million units.